Cierra N. Sharp

Cierra N. Sharp

May 23, 2016

Group 6 Copy 15
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Does hearing gum chewing increase stress in students?

    This study can help to uncover smaller stress factors that affect teens. Studying the effect of hearing gum...

    What risks do ticks confer to the humans and animals of Guam?

    There is an abundant population of ticks on Guam, which can cause devastating illness in animals. Many animals...

    Backer Badge Funded